Publication:
Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.

dc.contributor.authorAomar-Millán, Ismael Francisco
dc.contributor.authorSalvatierra, Juan
dc.contributor.authorHernández-Quero, José
dc.date.accessioned2023-02-09T10:45:31Z
dc.date.available2023-02-09T10:45:31Z
dc.date.issued2021-03-10
dc.identifier.doi10.1007/s11739-021-02690-3
dc.identifier.essn1970-9366
dc.identifier.pmcPMC7945597
dc.identifier.pmid33694056
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7945597/pdf
dc.identifier.unpaywallURLhttps://link.springer.com/content/pdf/10.1007/s11739-021-02690-3.pdf
dc.identifier.urihttp://hdl.handle.net/10668/17335
dc.issue.number4
dc.journal.titleInternal and emergency medicine
dc.journal.titleabbreviationIntern Emerg Med
dc.language.isoen
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.organizationHospital Universitario San Cecilio
dc.page.number1105-1106
dc.pubmedtypeLetter
dc.pubmedtypeComment
dc.rights.accessRightsopen access
dc.subject.meshAdrenal Cortex Hormones
dc.subject.meshAntibodies, Monoclonal, Humanized
dc.subject.meshHumans
dc.subject.meshInterleukin 1 Receptor Antagonist Protein
dc.subject.meshPneumonia
dc.subject.meshRetrospective Studies
dc.subject.meshSARS-CoV-2
dc.subject.meshCOVID-19 Drug Treatment
dc.titleAnakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number16
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PMC7945597.pdf
Size:
445.16 KB
Format:
Adobe Portable Document Format